Modern Healthcare5h
FDA warns Dexcom over continuous glucose monitor testing
The agency cited quality issues at facilities testing Dexcom’s G6 and G7 monitors, including inadequate validation and risk ...
Intelligent Bio Solutions’ FDA Clearance Process Remains on Track for 2025 U.S. Launch
On December 18, 2024, the Company announced the submission of its 510 (k) premarket notification to the U.S. Food and Drug Administration (FDA) for review and clearance of its Intelligent ...
kneat.com: Critical Service SaaS In The High-Growth Pharmaceutical Industry
Kneat's SaaS model automates validation processes in pharma and biotech, reducing errors and ensuring compliance. Learn why ...